Comparison of aortic valve allograft decellularization techniques in the rat

Journal of Biomedical Materials Research - Part A

Volumn 79, Issue 2, 2006, Pages 254-262

  Meyer, Steven R ^a   Chiu, Brian ^a   Churchill, Thomas A ^a   Zhu, Linfu ^a   Lakey, Jonathan R T ^a   Ross, David B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Allograft; Animal model; Decellularization; Heart valve; Tissue engineering

Indexed keywords

ANTIGENS; CARDIOVASCULAR SURGERY; CELLS; ENZYME KINETICS; HEART VALVE PROSTHESES; IMMUNIZATION;

ALLOGRAFTS; ANIMAL MODEL; DECELLULARIZATION; HEART VALVE; TISSUE ENGINEERING;

GRAFTS;

DETERGENT; EDETIC ACID; PHOSPHATE BUFFERED SALINE; TRITON X 100; TROMETAMOL; TRYPSIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA GRAFT; AORTA VALVE; AORTA WALL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DECELLULARIZATION; DISEASE MODEL; EXTRACELLULAR MATRIX; GRAFT FAILURE; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LOW TEMPERATURE; MALE; MICROSCOPY; NONHUMAN; OSMOTIC LYSIS; RAT;

ANIMALS; ANTIGENS, CD3; AORTIC VALVE; BIOCOMPATIBLE MATERIALS; EXTRACELLULAR MATRIX; HEART VALVE PROSTHESIS IMPLANTATION; HYDROXYPROLINE; OCTOXYNOL; OSMOSIS; RATS; RATS, INBRED LEW; TISSUE ENGINEERING; TRYPSIN; VIMENTIN;

EID: 33750462398     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30777     Document Type: Article

References (35)

1. O'Brien MF, Stafford EG, Gardner MA, Pohlner PG, McGiffin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987;94:812-823.
2. Baskett RJ, Ross DB, Nanton MA, Murphy DA. Factors in the early failure of cryopreserved homograft pulmonary valves in children: Preserved immunogenicity? J Thorac Cardiovasc Surg 1996;112:1170-1178.
3. Oei FB, Welters MJ, Knoop CJ, Vaessen LM, Stegmann AP, Weimar W, Bogers AJ. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients. Eur J Cardiothorac Surg 2000;18:466-472.
4. Welters MJ, Oei FB, Vaessen LM, Stegmann AP, Bogers AJ, Weimar W. Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation. Clin Exp Immunol 2001;124:353-358.
5. Hawkins JA, Breinholt JP, Lambert LM, Fuller TC, Profaizer T, McGough EC, Shaddy RE. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg 2000;119:324-330.
6. Meyer SR, Campbell PM, Rutledge JM, Halpin AM, Hawkins LE, Lakey JR, Rebeyka IM, Ross DB. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation. Eur J Cardiothorac Surg 2005;27:554-560.
7. Green MK, Walsh MD, Dare A, Hogan PG, Zhao XM, Frazer IH, Bansal AS, O'Brien MF. Histologic and immunohistochemical responses after aortic valve allografts in the rat. Ann Thorac Surg 1998;66 (Suppl.):S216-S220.
8. Legare JF, Lee TD, Creaser K, Ross DB. T lymphocytes mediate leaflet destruction and allograft aortic valve failure in rats. Ann Thorac Surg 2000;70:1238-1245.
9. Hoekstra F, Knoop C, Aghai Z, Jutte N, Mochtar B, Bos E, Weimar W. Stimulation of immune-competent cells in vitro by human cardiac valve-derived endothelial cells. Ann Thorac Surg 1995;60 (Suppl.):S131-S133.
10. Batten P, McCormack AM, Rose ML, Yacoub MH. Valve interstitial cells induce donor-specific T-cell anergy. J Thorac Cardiovasc Surg 2001;122:129-135.
11. Oei FB, Stegmann AP, Vaessen LM, Marquet RL, Weimar W, Bogers AJ. Immunological aspects of fresh and cryopreserved aortic valve transplantation in rats. Ann Thorac Surg 2001;71 (Suppl.):S379-S384.
12. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-666.
13. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve: A new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999;11 (Suppl. 1):194-200.
14. Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002;106 (Suppl. 1):163-168.
15. Olfert FD CB, McWilliam AA, editors. Guide to the care and use of experimental animals. Canadian Council of Animal Care, Ontario, Canada, 1993.
16. Yankah AC WH, Muller-Ruchholtz W. Antigenicity and fate of cellular components of heart valve allografts. In: Yankah AC, Hetzer R, Yacoub MH, editors. Cardiac Valve Allografts 1962-87. Current Concepts on the Use of Aortic and Pulmonary Allografts for Heart Valve Substitutes. Darmstadt: Steinkopff Verlag; 1988. pp77-87.
17. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;96:2144-2148.
18. Legare JF, Ross DB, Issekutz TB, Ruigrok W, Creaser K, Hirsch GM, Lee TD. Prevention of allograft heart valve failure in a rat model. J Thorac Cardiovasc Surg 2001;122:310-317.
19. Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967;18:267-273.
20. Oei FB, Welters MJ, Vaessen LM, Marquet RL, Zondervan PE, Weimar W, Bogers AJ. Heart valve dysfunction resulting from cellular rejection in a novel heterotopic transplantation rat model. Transpl Int 2000;13 (Suppl. 1):S528-S531.
21. Azakie T, Merklinger SL, McCrindle BW, Van Arsdell GS, Lee KJ, Benson LN, Coles JG, Williams WG. Evolving strategies and improving outcomes of the modified norwood procedure: A 10-year single-institution experience. Ann Thorac Surg 2001;72:1349-1353.
22. Kerman RH, Susskind B, Kerman D, Lam M, Gerolami K, Williams J, Kalish R, Campbell M, Katz S, Van Buren CT, Frazier H, Radovancevic B, Fife S, Kahan B. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. J Heart Lung Transplant 1998;17:789-794.
23. Thompson JS, Thacker LR II, Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: An analysis from the United Network of Organ Sharing Scientific Registry. Transplantation 2000;69: 2178-2186.
24. Jacobs JP, Quintessenza JA, Boucek RJ, Morell VO, Botero LM, Badhwar V, van Gelder HM, Asante-Korang A, McCormack J, Daicoff GR. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 2004;78:1703-1709.
25. Shaddy RE, Fuller TC, Anderson JB, Lambert LM, Brinkman MK, Profaizer T, Hawkins JA. Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation. Ann Thorac Surg 2004;77:1734-1739.
26. Armitage JM, Fricker FJ, del Nido P, Starzl TE, Hardesty RL, Griffith BP. A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. J Thorac Cardiovasc Surg 1993;105:464-472.
27. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102 (Suppl. 3):III44-III49.
28. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg 2001;71 (Suppl.):S428-S432.
29. Grauss RW, Hazekamp MG, van Vliet S, Gittenberger-de Groot AC, DeRuiter MC. Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. J Thorac Cardiovasc Surg 2003;126:2003-2010.
30. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 1998;14:279-284.
31. Courtman DW, Pereira CA, Omar S, Langdon SE, Lee JM, Wilson GJ. Biomechanical and ultrastructural comparison of cryopreservation and a novel cellular extraction of porcine aortic valve leaflets. J Biomed Mater Res 1995;29:1507-1516.
32. Hawkins JA, Hillman ND, Lambert LM, Jones J, Di Russo GB, Profaizer T, Fuller TC, Minich LL, Williams RV, Shaddy RE. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: Comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg 2003;126:247-252.
33. Cole WG, Chan D, Hickey AJ, Wilcken DE. Collagen composition of normal and myxomatous human mitral heart valves. Biochem J 1984;219:451-460.
34. Schenke-Layland K, Vasilevski O, Opitz F, Konig K, Riemann I, Halbhuber KJ, Wahlers T, Stock UA. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003;143:201-208.
35. Legare JF, Nanton MA, Bryan P, Lee TD, Ross DB. Aortic valve graft implantation in rats: A new functional model. J Thorac Cardiovasc Surg 2000;120:679-685.